$CBGL The Company believes this technology holds wide appeal to the developing worldwide cannabis industry, and potential allowing for significant cost reductions and meaningful efficacy enhancements. Additionally, the technology will allow for significantly faster onset of active cannabinoids ingredients, which are expected to be measured in minutes, versus oftentimes in hours for current generations of cannabinoid infusion technologies.

"At Cannabis Global we hold the opinion that not only will cannabis be soon deschecheduled and legalized within the United States, but in many other areas of the world," commented Arman Tabatabaei, Company CEO. "It is important for our Company to start on the PCT process as soon as is possible to ensure we will be able to capitalize on the expected wave of global cannabis legalization, especially relating to South East Asia and within the European Union where legalization and decriminalization is already well underway."

https://www.benzinga.com/pressreleases/20/11/...ery-system